secwatch / observer
8-K filed November 13, 2023, 6:59 PM ET ticker CNO CIK 0001224608
leadership confidence high sentiment neutral materiality 0.50

CNO extends CEO Bhojwani's contract to 2028 and renews poison pill through 2026

CNO Financial Group, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CNO Financial Group, Inc.: Filing of Certificate of Designations for Series F Junior Participating Preferred Stock and Certificate of Elimination for Series E Junior Participating Preferred Stock in connection with amended rights agreement (effective 2023-11-13).

Change
charter amendment
Effective
2023-11-13
Exact text from the filing
the Company will file with the office of the Secretary of State of the State of Delaware (i) on November 13, 2023 a Certificate of Designations (the “ Certificate of Designations ”) for the Series F Junior Participating Preferred Stock, par value $0.01 per share, of the Company relating to the Amended Rights Agreement, and (ii) on November 14, 2023 a Certificate of Elimination (the “ Certificate of Elimination ”) for the Series E Junior Participating Preferred Stock, par value $0.01 per share, of the Company relating to the Fourth Amended Rights Agreement.
View on SEC.gov

Browse all governance changes →

CNO Financial Group, Inc. filing history →

Source: SEC EDGAR
accession 0001224608-23-000067
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.